Validation of a sleep quality assessment tool for spine disorder patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to validate the Single-item Sleep Quality Scale (SQS) for patients with spine disorders by translating it into German and Italian. The research will be conducted in two stages: first, the translation and cross-cultural adaptation of the SQS, followed by an evaluation of its validity, reproducibility, and responsiveness in assessing sleep quality among these patients. By utilizing this tool, healthcare providers can better understand the impact of sleep quality on patients suffering from back disorders. The study addresses a significant gap in the assessment of sleep quality in this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* both male and female patients
* German-speaking or Italian-speaking
* diagnosis of spine pathology
* age ≥ 14 years
* cognitively intact (self-reported)

Exclusion Criteria:

* pregnancy (self-reported)
* medical and/or pharmacological treatment for sleep disorders
* melatonin intake
* daily use of smart-watch or applications for automatic sleep detection
* inability to give informed consent

Where it's running

• Schulthess Klinik
  Zurich, Canton of Zurich, Switzerland Recruiting

Study contacts

• Study coordinator: Jacopo Vitale, Dr. PhD
• Email: jacopo.vitale@kws.ch
• Phone: 0443857148

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Heart-friendly medicines to protect chest-area cancer patients from radiation damage

  This Phase 2 trial tests whether taking atorvastatin and lisinopril can reduce heart damage in adults with chest-area cancers who receive radiation therapy.

  Recruiting Phase 2 UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina · NCT07685938

• Spine tumor registry tracking outcomes after separation surgery and radiation

  This registry will collect information to see what outcomes adults with primary or metastatic spine tumors have after separation surgery followed by radiation.

  Recruiting at 5 sites Ohio State University Comprehensive Cancer Center · Indianapolis, Indiana and 4 other locations · NCT07225491

• Radiofrequency ablation and bone augmentation plus radiotherapy vs radiotherapy alone for spinal metastases

  This trial will test whether adding radiofrequency ablation and bone augmentation to radiotherapy helps people with metastatic spine disease (T5-L5) have fewer skeletal-related events and less pain.

  Recruiting University of Minnesota · Minneapolis, Minnesota · NCT07090122

• Evaluating radiofrequency ablation and stabilization for metastatic spine lesions

  This study is testing if a new treatment that combines radiofrequency ablation and stabilization can help people with certain types of spine tumors feel better by looking at changes in their lesions after treatment.

  Recruiting National and Kapodistrian University of Athens · Athens, Athens · NCT06716294

• Radiation treatment for high-risk spine cancer patients

  This study is testing a new type of radiation treatment for patients with cancer that has spread to the spine to see if it can help manage their condition without needing major surgery.

  Recruiting Phase 2 Stony Brook University · Stony Brook, New York · NCT06165419

• Radiotherapy for patients with minimally symptomatic spinal metastases

  This study tests whether giving early radiation therapy to patients with mild spinal metastases can help prevent serious bone problems and improve their overall health.

  Recruiting Phase 1/2 Baptist Health South Florida · Miami, Florida · NCT05534321

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.